FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Molekulare Mechanismen der Organfibrose
Reallocation / Closing: 30.09.2022
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 3 – Rheumatology and Immunology
Lehrstuhl für Innere Medizin III
Overview
Publications
(354)
Research Grants
(2)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Evidence of innate lymphoid cell redundancy in humans (2016)
Vely F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, et al.
Journal article
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients (2016)
Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, et al.
Journal article
Effects of In utero environment and maternal behavior on neuroendocrine and behavioral alterations in a mouse model of prenatal trauma (2016)
Golub Y, Canneva F, Funke R, Frey S, Distler J, von Hörsten S, Freitag CM, et al.
Journal article
Tocilizumab for systemic sclerosis: implications for future trials (2016)
Distler O, Distler J
Journal article, other
Corrigendum to "Fc-gamma receptors are not involved in cartilage damage during experimental osteoarthritis" [Osteoarthritis Cartilage 23 (2015) 1221-1225] (2016)
Stock M, Distler A, Distler J, Beyer C, Ruiz-Heiland G, Ipseiz N, Seeling M, et al.
Journal article, Erratum
Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies (2016)
Riemekasten G, Beissert S, Distler J, Kreuter A, Mueller-Ladner U
Journal article
Sirt1 regulates canonical TGF-? signalling to control fibroblast activation and tissue fibrosis (2016)
Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, Schett G, Distler J
Journal article
Activating transcription factor 3 regulates canonical TGF? signalling in systemic sclerosis (2016)
Mallano T, Palumbo-Zerr K, Zerr P, Zeller B, Beyer C, Dees C, Huang J, et al.
Journal article
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis (2016)
Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, et al.
Journal article, Original article
The transcription factor GLI2 as a downstream mediator of transforming growth factor-?-induced fibroblast activation in SSc (2016)
Liang R, Sumova B, Cordazzo C, Mallano T, Zhang Y, Wohlfahrt T, Dees C, et al.
Journal article
‹
1
...
28
29
30
31
32
...
35
›